| 30098161 |
Kirby Schwartzbauer |
2026-05-13 13:39:24.659
|
Hospitals: Report Clinical Diagnostic Laboratory Data by July 31 |
| 30109734 |
James Marko |
2026-05-14 13:27:49.365
|
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R21 - Effective April 1, 2026 |
| 30097909 |
James Marko |
2026-05-12 15:49:25.159
|
Prior Authorization Submission Updates in NMP |
| 30110200 |
James Marko |
2026-05-14 13:59:18.655
|
Epidural Steroid Injections for Pain Management (L39240) - R5 - Effective April 16, 2026 |
| 29716970 |
Kirby Schwartzbauer |
2026-05-14 17:52:27.538
|
Introducing the Noridian Educational Experience (NEE) |
| 30112336 |
James Marko |
2026-05-14 14:08:41.722
|
Treatment of Varicose Veins of the Lower Extremities (L34209) - R13 - Effective May 14, 2026 |
| 30109955 |
James Marko |
2026-05-14 13:40:20.411
|
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R28 - Effective April 1, 2026 |
| 30113264 |
Michael Abner |
2026-05-14 18:56:22.506
|
AKI & ESRD Billing: Ending the AX Modifier Requirement - Revised |
| 30112920 |
Kirby Schwartzbauer |
2026-05-14 17:15:30.821
|
MLN Connects - May 14, 2026 |
| 30110217 |
James Marko |
2026-05-14 13:59:25.455
|
Epidural Steroid Injections for Pain Management (L39240) - R5 - Effective April 16, 2026 |
| 29716952 |
Kirby Schwartzbauer |
2026-05-14 17:52:24.472
|
Introducing the Noridian Educational Experience (NEE) |
| 30109887 |
James Marko |
2026-05-14 13:35:39.911
|
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R35 - Effective April 1, 2026 |
| 30097661 |
Kirby Schwartzbauer |
2026-05-11 17:07:15.305
|
CERT Awareness Month: 2026 CERT Documentation Deadline |
| 30097673 |
Kirby Schwartzbauer |
2026-05-11 17:07:19.4
|
CERT Awareness Month: 2026 CERT Documentation Deadline |
| 30109819 |
James Marko |
2026-05-14 13:31:52.984
|
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R13 - Effective May 14, 2026 |
| 30110268 |
James Marko |
2026-05-14 14:04:07.06
|
Billing and Coding: MRI and CT Scans of the Head and Neck (A57204) - R16 - Effective January 1, 2026 |
| 30110285 |
James Marko |
2026-05-14 14:04:16.108
|
Billing and Coding: MRI and CT Scans of the Head and Neck (A57204) - R16 - Effective January 1, 2026 |
| 30109751 |
James Marko |
2026-05-14 13:27:55.962
|
Billing and Coding: MolDX: Repeat Germline Testing (A57331) - R21 - Effective April 1, 2026 |
| 30109938 |
James Marko |
2026-05-14 13:40:12.175
|
Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT) (A57526) - R28 - Effective April 1, 2026 |
| 30109802 |
James Marko |
2026-05-14 13:31:41.586
|
Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (A57891) - R13 - Effective May 14, 2026 |
| 30112353 |
James Marko |
2026-05-14 14:08:48.444
|
Treatment of Varicose Veins of the Lower Extremities (L34209) - R13 - Effective May 14, 2026 |
| 30109870 |
James Marko |
2026-05-14 13:35:30.867
|
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R35 - Effective April 1, 2026 |
| 30112908 |
Kirby Schwartzbauer |
2026-05-14 17:15:24.389
|
MLN Connects - May 14, 2026 |
| 30004554 |
Kirby Schwartzbauer |
2026-05-14 18:53:22.579
|
Claim Adjustments to Correct Conversion Factor for Quality Payment Program (QPP) Claims - Resolved 05/14/26 |
| 30097943 |
James Marko |
2026-05-12 15:49:37.082
|
Prior Authorization Submission Updates in NMP |
| 30098127 |
Kirby Schwartzbauer |
2026-05-13 13:33:47.099
|
First Quarter Top Return to Provider (RTP) Claim Errors |
